Advertisement
Moderna, Inc.

Moderna, Inc. (MRNA) Stock Overview

Explore Moderna, Inc.’s financial performance, market position, analyst ratings, and future outlook.

MRNA●NASDAQ
HealthcareBiotechnology
$51.59
$2.53(5.16%)
U.S. Market opens in 16h 6m
Advertisement

Moderna, Inc. (MRNA)

Meyka AI Score

Z

Key Financials

Market Cap20.4B
P/E Ratio-6.01
EPS (TTM)$-8.14
ROE-0.37%
Fundamental Analysis

AI Price Forecasts

1 Month$51.89
3 Months$50.62
1 Year Target$54.96

MRNA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Moderna, Inc. (MRNA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 51.64, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $54.96.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -6.01 and a market capitalization of 20.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
5.16%
5-Day Change
9.14%
1-Month Change
9.07%
3-Month Change
-10.74%
6-Month Change
102.39%
Year-to-Date (YTD) Change
74.94%
1-Year Change
89.18%
3-Year Change
-59.98%
5-Year Change
-74.96%
All-Time (Max) Change
177.37%

Contact Information

https://www.modernatx.com
617 714 6500
325 Binney Street, Cambridge, MA, 02142

Company Facts

5,800 Employees
IPO DateDec 7, 2018
CountryUS
Actively Trading

Frequently Asked Questions